Attached files
| file | filename |
|---|---|
| 8-K - 8-K - Altimmune, Inc. | v466109_8k.htm |
| EX-99.1 - EXHIBIT 99.1 - Altimmune, Inc. | v466109_ex99-1.htm |
| EX-16.1 - EXHIBIT 16.1 - Altimmune, Inc. | v466109_ex16-1.htm |
| EX-10.3 - EXHIBIT 10.3 - Altimmune, Inc. | v466109_ex10-3.htm |
| EX-10.2 - EXHIBIT 10.2 - Altimmune, Inc. | v466109_ex10-2.htm |
| EX-10.1 - EXHIBIT 10.1 - Altimmune, Inc. | v466109_ex10-1.htm |
| EX-3.3 - EXHIBIT 3.3 - Altimmune, Inc. | v466109_ex3-3.htm |
| EX-3.1 - EXHIBIT 3.1 - Altimmune, Inc. | v466109_ex3-1.htm |
Exhibit 3.2
CERTIFICATE OF AMENDMENT
TO THE
AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
PHARMATHENE, INC.
PharmAthene, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify:
FIRST: That at a meeting of the Board of Directors of the Corporation (the “Board”) resolutions were duly adopted setting forth a proposed amendment of the Certificate of Incorporation of the Corporation, declaring said amendment to be advisable. The resolution setting forth the proposed amendment is as follows:
RESOLVED, that the Amended and Restated Certificate of Incorporation of the Corporation be amended by changing Article I thereof so that, as amended, said Article shall be and read as follows:
ARTICLE I
NAME
The name of this corporation is Altimmune, Inc. (the “Corporation”).
SECOND: That said amendment was duly adopted in accordance with the applicable provisions of Section 242 of the General Corporation Law of the State of Delaware.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Corporation to be signed this 4th day of May, 2017.
| PHARMATHENE, INC. | ||
| By: | /s/ William Enright | |
| Name: | William Enright | |
| Title: | Chief Executive Officer | |
[Signature Page to Amendment to Charter]